Dr C Michael Gibson (Beth Israel Deaconess Medical Center, Boston, MA, USA) spoke to us at C3 2019 about his thoughts and experiences on clinical trials and how the landscape of clinical trials is changing.
Speaker’s Disclosures: C Michael Gibson wishes to declare relationships with Johnson + Johnson and Apple.
1. Share your thoughts and experiences of clinical trials and how the landscape is changing (0:04)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
Share this Video
Related Videos In Interventional Cardiology
Hyo-Soo Kim, ESC 2021 – HOST-EXAM Study
Dr Hyo-Soo Kim (Interventional Cardiologist, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) kindly shared his thoughts on the HOST-EXAM study and the effectiveness of clopidogrel versus aspirin for long-term maintenance after stenting, and the cost-effectiveness analysis from this data, from the virtual ESC Congress 2021. Questions What did the HOST-EXAM study teach us […]
Peter Smits, ESC 2021 – High Bleeding Risk After Coronary Stenting
Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC […]
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!